Novo Nordisk Share repurchase programme

On 15 August 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission’s regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules. Under the programme Novo Nordisk will repurchase B shares for an amount of up to DKK 1.7 billion in the period from 15 August 2008 to 19 December 2008. Since the announcement... 

Tags: Buyback, Copenhagen, Denmark, diabetes, Diabetes Care, European Commission, healthcare, hormone replacement therapy, Hormone therapy, London, New York Stock Exchange, Novo Nordisk, pharmaceutical products, Safe Harbour

International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive

The International Diabetes Federation (IDF) announced today that it is bringing together key opinion leaders to push for action to secure care for the thousands of children with diabetes in developing countries without access to care. The meeting, Access to Essential Diabetes Medicines for Children in the Developing World, will be held on Saturday, October 25 in London, United Kingdom. The International... 

Tags: Asia, Azerbaijan, Bolivia, Democratic Republic of Congo, diabetes, Diabetes Australia-NSW, Diabetes Care, Ecuador, Fiji, healthcare professionals, healthcare providers, healthcare systems, HOPE, India, International Diabetes Federation, Jean-Claude Mbanya, London, Mali, Martin Silink, Nepal, Nigeria, Papua New Guinea, pharmaceutical industry, Rwanda, Sri Lanka, Sub-Saharan Africa, Sudan, sustainable solutions, the Philippines

Apieron, Inc. Announces Appointment of Holly McGarraugh as President and Chief Executive Officer

Apieron, Inc. (www.apieron.com) announced today that its Board of Directors has appointed Holly McGarraugh as president and CEO of the company, effective immediately. Ms. McGarraugh replaces Rich Lotti, who resigned to pursue other business interests. “We chose Holly for the CEO position because of her strong commercialization experience,” said Wende Hutton, Apieron Board member and partner... 

Tags: Abbott, Abbott Labs, Acquisition, Alliance, Apieron Inc., asthma, California, Canaan Partners, Cerexa Inc., Chimerix Inc., Connecticut, Dexcom Inc., Diabetes Care, FDA, healthcare, healthcare investments, healthcare team, Holly McGarraugh, in vivo products, India, IPO, Israel, Management Change, medical solutions, Menlo Park, Regenerative medicine, ReVision Optics Inc., Rich Lotti, start-up

novo nordisk, nurse hiring in london